| High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa FY Tso, SJ Lidenge, PB Peña, AA Clegg, JR Ngowi, J Mwaiselage, ... International Journal of Infectious Diseases 102, 577-583, 2021 | 239 | 2021 |
| Disease patterns and clinical outcomes of patients admitted in intensive care units of tertiary referral hospitals of Tanzania HR Sawe, JA Mfinanga, SJ Lidenge, BCT Mpondo, S Msangi, E Lugazia, ... BMC international health and human rights 14, 1-8, 2014 | 123 | 2014 |
| Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma FY Tso, SJ Lidenge, LK Poppe, PB Peña, SR Privatt, SJ Bennett, ... PLoS One 16 (3), e0247640, 2021 | 69 | 2021 |
| RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism FY Tso, AV Kossenkov, SJ Lidenge, O Ngalamika, JR Ngowi, ... PLoS pathogens 14 (1), e1006844, 2018 | 55 | 2018 |
| Influence of HIV/AIDS on cervical cancer: a retrospective study from Tanzania RS Chambuso, S Shadrack, SJ Lidenge, N Mwakibete, RM Medeiros Journal of global oncology 3 (1), 72-78, 2017 | 52 | 2017 |
| Similar immunological profiles between african endemic and human immunodeficiency virus type 1–associated epidemic Kaposi Sarcoma (KS) patients reveal the primary role of KS … SJ Lidenge, FY Tso, O Ngalamika, JR Ngowi, Y Mortazavi, EH Kwon, ... The Journal of infectious diseases 219 (8), 1318-1328, 2019 | 25 | 2019 |
| Comparative transcriptome analysis of endemic and epidemic Kaposi’s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis SJ Lidenge, AV Kossenkov, FY Tso, J Wickramasinghe, SR Privatt, ... PLoS pathogens 16 (7), e1008681, 2020 | 21 | 2020 |
| The Kaposi’s sarcoma-associated herpesvirus (KSHV) gH/gL complex is the predominant neutralizing antigenic determinant in KSHV-infected individuals Y Mortazavi, SJ Lidenge, T Tran, JT West, C Wood, FY Tso Viruses 12 (3), 256, 2020 | 21 | 2020 |
| Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors SJ Lidenge, T Tran, FY Tso, JR Ngowi, DM Shea, J Mwaiselage, C Wood, ... International Journal of Infectious Diseases 95, 204-209, 2020 | 20 | 2020 |
| Lack of CD8+ T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors SJ Lidenge, FY Tso, O Ngalamika, J Kolape, JR Ngowi, J Mwaiselage, ... Oncotarget 11 (17), 1556, 2020 | 17 | 2020 |
| SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study O Ngalamika, SJ Lidenge, MC Mukasine, M Kawimbe, P Kamanzi, ... International Journal of Infectious Diseases 127, 106-115, 2023 | 13 | 2023 |
| Antiretroviral therapy for HIV-associated cutaneous kaposi's sarcoma: clinical, HIV-related, and sociodemographic predictors of outcome O Ngalamika, S Munsaka, SJ Lidenge, JT West, C Wood AIDS research and human retroviruses 37 (5), 368-372, 2021 | 9 | 2021 |
| Outcome markers of ART-treated HIV+ patients with early stage Kaposi’s sarcoma O Ngalamika, FY Tso, S Lidenge, S Munsaka, D Shea, C Wood, J West PLoS One 15 (7), e0235865, 2020 | 9 | 2020 |
| Viral and immunological analytes are poor predictors of the clinical treatment response in Kaposi’s sarcoma patients SJ Lidenge, FY Tso, Y Mortazavi, JR Ngowi, DM Shea, J Mwaiselage, ... Cancers 12 (6), 1594, 2020 | 8 | 2020 |
| Antibody epitope profiling of the KSHV LANA protein using VirScan SJ Bennett, D Yalcin, SR Privatt, O Ngalamika, SJ Lidenge, JT West, ... PLoS Pathogens 18 (12), e1011033, 2022 | 6 | 2022 |
| Clinicopathological Characteristics and Outcomes of Anal Squamous Cell Carcinoma Patients With and Without HIV Infection in Sub-Saharan Africa E Mduma, N Dharsee, K Samwel, CJ Mwita, SJ Lidenge JCO Global Oncology 9, e2200394, 2023 | 5 | 2023 |
| Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection SJ Bennett, D Yalcin, SR Privatt, O Ngalamika, SJ Lidenge, JT West, ... PLoS Pathogens 20 (2), e1012023, 2024 | 3 | 2024 |
| SARS‐CoV‐2‐Specific T Cell Immunity in HIV‐Associated Kaposi Sarcoma Patients in Zambia O Ngalamika, MC Mukasine, P Kamanzi, M Kawimbe, A Mujajati, FY Tso, ... Journal of Immunology Research 2022 (1), 2114285, 2022 | 3 | 2022 |
| High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa FY Tsoa, S Lidenge, P Peñaa, A Clegg, J Ngowi, O Ngalamika, P Julius, ... Elsevier, 2020 | 3 | 2020 |
| Viral Epitope Scanning Reveals Correlation between Seasonal HCoVs and SARS-CoV-2 Antibody Responses among Cancer and Non-Cancer Patients SJ Lidenge, D Yalcin, SJ Bennett, O Ngalamika, BB Kweyamba, CJ Mwita, ... Viruses 16 (3), 448, 2024 | 2 | 2024 |
